Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Voyager Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
VYGR
Nasdaq
2834
www.voyagertherapeutics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Voyager Therapeutics, Inc.
Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage
- Dec 10th, 2025 12:14 pm
We're A Little Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Rate
- Nov 24th, 2025 5:21 am
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
- Nov 10th, 2025 7:15 am
Voyager Therapeutics: Q3 Earnings Snapshot
- Nov 10th, 2025 6:14 am
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
- Nov 10th, 2025 6:01 am
Voyager Reports Third Quarter 2025 Financial and Operating Results
- Nov 10th, 2025 6:01 am
Moderna (MRNA) Reports Q3 Loss, Tops Revenue Estimates
- Nov 6th, 2025 6:15 am
Owning 44% shares,institutional owners seem interested in Voyager Therapeutics, Inc. (NASDAQ:VYGR),
- Oct 28th, 2025 5:52 am
Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock?
- Oct 9th, 2025 8:19 am
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst
- Sep 15th, 2025 12:00 pm
Voyager to Present at Upcoming Investor Conferences
- Aug 26th, 2025 5:00 am
Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates
- Aug 6th, 2025 3:30 pm
Voyager Therapeutics: Q2 Earnings Snapshot
- Aug 6th, 2025 2:29 pm
Voyager Reports Second Quarter 2025 Financial and Operating Results
- Aug 6th, 2025 2:01 pm
Sector Update: Health Care Stocks Climb Late Afternoon
- Jul 16th, 2025 2:08 pm
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach
- Jul 16th, 2025 5:00 am
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
- Jun 10th, 2025 5:00 am
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
- Jun 1st, 2025 4:05 am
With 46% ownership, Voyager Therapeutics, Inc. (NASDAQ:VYGR) has piqued the interest of institutional investors
- May 20th, 2025 10:24 am
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication
- May 15th, 2025 5:00 am
Scroll